Ardea Bioscience, Inc. (RDEA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

2131 PALOMAR ROAD CARLSBAD, CA 92011

Plans to evaluate its strategic options, including mergers, acquisitions or liquidation of the company, following the discontinuance of development of iseganan hydrochloride, a drug for the preventation of ventilator-associated pneumonia. Is transitioning its operations to outside consultants.

View SEC Filings from RDEA instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding RDEA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RDEA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

JOHNSON CRAIG A

  • Director
No longer subject to file 2012-06-19 0

DAVIS STEPHEN EVP & COO

  • Officer
No longer subject to file 2012-06-19 0

MANHARD KIMBERLY SVP, REGULATORY & DEV OPS

  • Officer
No longer subject to file 2012-06-19 0

HAGERTY DAVID T SENIOR VP & CMO

  • Officer
No longer subject to file 2012-06-19 0

QUART BARRY D PRESIDENT AND CEO

  • Officer
  • Director
No longer subject to file 2012-06-19 0

TANG KEVIN C

  • Director
  • 10% Owner
No longer subject to file 2012-06-19 0

POYHONEN JOHN

  • Director
No longer subject to file 2012-06-19 0

FUCHS HENRY J

  • Director
No longer subject to file 2012-06-19 0

DIXON WENDY L

  • Director
No longer subject to file 2012-06-19 0

BECK JOHN W SVP, FINANCE & OPERATIONS, CFO

  • Officer
No longer subject to file 2012-06-19 0

BAKER FELIX

BAKER JULIAN

BAKER BROS ADVISORS LLC

  • Director
  • 10% Owner
No longer subject to file 2012-06-19 0

ASTRAZENECA PLC

  • 10% Owner
0 2012-04-21 0

BAKER BROS ADVISORS LLC

  • Director
  • 10% Owner
0 2012-04-12 0

BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

BAKER FELIX

BAKER JULIAN

  • Director
  • 10% Owner
4,922,226 2012-02-01 0

14159 CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
116,454 2012-02-01 0

TANG KEVIN C

TANG CAPITAL MANAGEMENT LLC

TANG CAPITAL PARTNERS LP

  • Director
  • 10% Owner
3,815,723 2012-02-01 0

BAKER FELIX

  • Director
  • 10% Owner
0 2012-01-03 0

BAKER BROS. CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
126,709 2011-06-30 0

REMINGTON JACK

  • Director
0 2011-01-03 0

KRUEGER CHRISTOPHER W SVP & CBO

  • Officer
933 2010-07-23 0

BAKER BIOTECH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
1,646,964 2008-12-19 0

BAKER / TISCH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
99,636 2008-12-19 0

ANDREEFF DANE

  • 10% Owner
1,220,779 2008-01-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments